GSK’s GLISTEN Phase III Trial of Linerixibat Meets...
Category : Clinical Trial Update 9 May 2025GSK plc announced positive results from the GLISTEN phase III trial evaluating linerixibat, an inves...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Boehringer Starts Phase II Trial for Oral Drug in...
Category : Clinical Trial Update 9 May 2025Boehringer Ingelheim announces the start of the JADE phase II clinical study (NCT06769048), investig...
Everest Medicines Announces NMPA Full Approval of...
Category : Approval/Launch 8 May 2025Everest Medicines a biopharmaceutical company focused on the discovery, clinical development, manufa...
Lilly Deepens ALS Pipeline With $415M Alchemab Lic...
Category : Licensing/Collaboration Deal 8 May 2025The Alchemab deal will further strengthen Lilly’s early-stage pipeline for amyotrophic lateral...
Data from Its Ongoing Phase 2 ENSURE Study at EASL...
Category : Clinical Trial Update 8 May 2025End of treatment (EOT) data from Cohort 4 of the ENSURE study suggest that patients responding to pr...
Latest Newsletter Post
-
Boehringer Starts Phase II Trial fo..
9 May 2025
-
GSK’s GLISTEN Phase III Trial of Li..
9 May 2025
-
Data from Its Ongoing Phase 2 ENSUR..
8 May 2025
-
Lilly Deepens ALS Pipeline With $41..
8 May 2025
-
Everest Medicines Announces NMPA Fu..
8 May 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com